ANI PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ani Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2023.
  • Ani Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$19.7M, a 334% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $67.4M.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$5.13M, a 103% decline from 2021.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $195M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $67.4M +$72.6M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$5.13M -$200M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $195M +$196M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$1.44M -$2.69M -215% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $1.25M +$29.1M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$27.8M -$100M -138% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $72.4M +$73.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$729K -$1.8M -168% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $1.07M -$171M -99.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $172M +$175M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$3.69M -$4.13M -938% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $440K Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.